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Comparison of Sporadic and Hereditary Forms of Medullary
Thyroid Carcinoma
M. Rosenberg-Bourgin,* P. Gardet,* R. de Sahb,* M. Schlumberger,* B. Caillou,'
M. Guilloud-Bataille,* J.P. IVavagli,* N. Feingold,* and C. Parmentier*

Between 1960 and 1988, 185 patients with medullary thyroid carcinoma (MTC) were followed at the
Inslilul Gustave Roussy in France. The screening of the family members by calcitonin measurement
(basal or after pentagastrin stimulation) has led lo the characterization of 38 sporadic cases and 44
hereditary cases. Among the hereditary cases are seven families wilh MTC only and two families with
multiple endocrine neoplasia type 2A (MEN 2A). MTC only cases and MEN 2B cases are present as
apparently sporadic forms. Hereditary cases consisted of 26 females and 18 males; the male.-female
ratio was 21:17 in sporadic cases. Ten ofthe sporadic patients were deceased (mean age 46 years)
compared to three of the hereditary cases (mean age 59 years). The age at diagnosis was 44 years for
the sporadic patients and 35 years for the hereditary MTC only patients wilh clinical manifestations.
Histologic data from the sporadic and hereditary patients showed lhal the tumor is mostly unilateral
without C-cell hyperplasia in sporadic cases and bilateral with C-cell hyperplasia in hereditary cases.
The location of tumors was quite variable among the sporadic cases and moslly localized to the middle
part oflhe thyroid lobes in the hereditary cases. Our dala suggest lhal the age at diagnosis is later in
sporadic forms of MTC and that the age at diagnosis is later in the hereditary forms of MTC only
compared to those withMEN2A. (Henry Ford HospMedJ 1989;37:141-3)

I

n France a national epidemiologic study was undertaken on
the medullary thyroid carcinoma (MTC) cases collected by
the French medullary study group (Group d'Etude des Tumeurs
a Calcitonine [GETC]) directed by Calmettes (1). This study had
two objectives; an epidemiological description of patients, and a
genetic analysis of families. We performed famity investigations to compare the hereditary and sporadic forms of the disease (2) as well as the expression of MTC in different "MTC
onty" families (3) and the multiple endocrine neoplasia type 2A
(MEN 2A) families.
In families tenned "MTC onty," the parients manifested no
other associated endocrinopalhies whereas in MEN 2A families
some patients had pheochromocytomas and/or hyperparathyroidism. We report an anatysis on the data collected at
the Institut Gustave Roussy (IGR) as a preliminary step of the
national study.

Methods
This retrospective study concems the French cases of MTC
diagnosed and followed at the IGR between 1968 and 1988.
Among the 185 reported cases, onty those with famity screening
were included in this analysis. When MTC was detected and
confirmed, screening for pheochromocytoma and parathyroid
disease was systematically undertaken. Screening for cases of
MTC in the family was performed by measuring plasma calcitonin (CT) levels (basal and after pentagastrin stimulation) and
by echography of the thyroid. I f these investigations were negative, we recommended that they be repeated in one or two years.
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The questionnaire used was designed to address several issues; individual and family demographic data; characteristics of
the MTCs inctuding the circumstances of diagnosis, the clinical
features, the histology, and the course of the disease; and the
associated features such as pheochromocytoma, hyperparathyroidism, or congenital abnormalities. At the IGR the
questionnaire was completed by one investigator who atso consulted the patients' medical records. Statistical analyses were
carried out using chi-square (with Yates' conection if necessary)
and the Student t test.

Results
From 185 cases of MTC followed at the IGR, family studies
could be performed on only 47 index cases. No other cases of
MTC were detected in the families of 38 index cases which were
then considered as apparently sporadic cases. Other cases of
MTC had been diagnosed in the famity of nine cases, and 35
new patients with MTC were found (Table 1). These 82 patients
were screened for other endocrinopalhies and accordingly di-
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Table 1
Distribution of Sporadic and Hereditary MTC Patients

Index Cases
Sporadic
Hereditary

38
9

Family Screening Results
Positive Screening
Negative
Clinical
CT Testing
Screening
0
12

0
23

128
63

Table 2
Comparison of MTC Only, MEN 2A Patients, and MEN 2B
Patients

Number of patients
Sex (male/female)
Mean age at MTC diagnosis (years)
SD
Clinical manifestations (%)
Thyroid nodule
Cervical adenopathy
Diarrhea
Flushing
Neck sensitivity
Metastases (%)
Average follow-up (years)
Death (%)

142

MEN 2A

MEN 2B

47
21/26
41
14

7
2/5
34
1(1

5
3/2
12
8

78
36
34
17
6
62
6
28

43
29
14
29
0
86
9
0

20
20
0
0
0
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Sporadic
Sex (male/female)
Mean age at diagnosis (years)

SD

vided in three groups; MTC onty, MEN 2A, and MEN 2B
patients.
The characteristics of patients with clinical manifestations are
described in Tabte 2, Among MTC onty patients, the 21 who
were diagnosed by pentagastrin-stimulated CT screening had a
mean age at diagnosis of 26 years (range 11 to 60 years) which
was tess than that for those with clinical manifestations. Men
and women had a different age at diagnosis (47 versus 37 years, t
test P < 0.02) for the group with clinical manifestations which
was not observed on those detected by the screening procedures.
Thyroid nodules and cervical adenopathy are the most frequent
clinical manifestations. Diarrhea is a common expression ofthe
disease in MTC onty patients, whereas flushing is found most
frequently in MEN 2A patients. No significant difference in the
three groups was observed for frequency of metastases (more
than 60% in each group). Distant metastases (liver, lung, bone)
were as frequent as node invasion atone; 36% versus 26% for
MTC only, and 50% versus 50% for MEN 2A. No distant metastases were observed in MEN 2B patients.
Atl MEN 2B patients were apparently sporadic cases. Those
affected were mainly children and are not included in our analysis. The mean age at MTC diagnosis was 12 years (Tabte 2).
MEN 2A was found onty among the hereditary cases with a
mean age of diagnosis for MTC of 34 years. The diagnosis of
other endocrinopathies was made at tater ages (average 40
years). Seven patients had other endocrinopathies diagnosed between five and 30 years after the MTC diagnosis. Two pafients
had other endocrinopathies diagnosed at the same time as the
MTC. Most of these patients had pheochromocytomas; six had
pheochromocytoma atone, and two were associated with parathyroid disease. One patient had hyperparathyroidism atone.

MTC only

Table 3
Comparison of Clinical Characteristics Between Sporadic
and Hereditary MTC

m6
0

Clinical features (%)
Thyroid nodule
Diarrhea
Flushing
Cervical adenopathy
Neck sensitivity
Metastases (%)
Node invasion only
Distant metastases'*
Death
Mean age al death (years)
SD

Hereditary

14/19
43.6
i.'

6/5
34.9
11

75
30
15
45
9
61
33
28
10(30%)
46.3
17

81
45
18
9
0
55
36
19
3 (27%)
59
7

'Distant metastases include liver, lung, and bone for sporadic forms and lung only for
hereditary forms.

In comparing sporadic and hereditary MTC, we evaluated
only patients who had similar circumstances of diagnosis as
those with MTC onty. Patients detected in the course of famity
investigations were excluded from this comparative anatysis.
The clinical characteristics reported in Tabte 3 show no statistical difference between the two forms. However, a significant
difference was found in pathologic features (Tabte 4). Sporadic
forms of MTC present mostly as unilateral tumors without preferential localization and no C-cetl hyperplasia, whereas hereditary forms present mostiy as bilateral tumors with a preferential
localization in the median part of the thyroid lobe and in association with C-cell hyperplasia.
A comparison between MTC onty and MEN 2A families suggests that the age at diagnosis in the MTC onty group is tater than
in the MEN 2A group (39 versus 30 years) (Table 5). However,
the age of screening was younger in the MEN 2A group (23 versus 31 years). To avoid bias we compared two families in which
the age of screening was the same (25 years); age at MTC diagnosis was 42 years (n = 4; SD = 4.79) forthe MTC onty famity
and 31 years (n = 6; SD = 8.99) forthe MEN 2A famity. Age at
MTC diagnosis was tater for MTC onty families, but this was not
statistically significant. No significant difference was noted for
other clinical and pathologic features.
Table 4
Comparison Between the Pathologic Characteristics
of Sporadic and Hereditary MTC

Tumor
Topography

Unilateral
Bilateral

Tumor
Localization

Upper
Median
Lower

C-cell
Hyperplasia

Ycs
No
Unknown

Chi-Square

Sporadic

Hereditary

25
4

2
24

7
5
5

2
14
3

P < 0.05

3
8
22

10
3
21

P < 0.05

P < 10"^
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Discussion
This study was one of the first steps in the national epidemiologic study of MTC. The questionnaire created by members of the French medullary study group was tested in the IGR
and seemed to answer the objectives of the GETC. The comparison between sporadic and hereditary forms provides significant resutts onty for pathologic features; bilateratity, median localization, and C-cell hyperplasia for hereditary forms; and
unilaterality, no preferential localization, and lack of C-cell hyperplasia for sporadic forms. These results concur with other
studies (4) and are in concordance with the two-mutationalevent theory in MTC (5).
For other epidemiologic characteristics (age at diagnosis,
clinical features, metastases, and mortality), no statistical difference was found which is contrary to thefindingsof other studies (4,6). As in other studies, our results show that the age at
diagnosis is younger in the hereditary form than in the sporadic
form. Absence of statistical significance might be explained by
the small size of our sample, but the inclusion of other French
MTC cases should answer that objection. The patients included
in our analyses are different from those in other studies in that
patients with both MTC only and MEN 2 were studied separately since the age at diagnosis of MTC in MEN 2A families is
younger than in MTC onty families (3,7); the mean age at diagnosis might be higher in our sample of hereditary cases.
tn comparing MEN 2A famifies with MTC only families, no
statistical difference in disease characteristics was found. Although the age at diagnosis of MTC is younger in MEN 2A families, a larger sample is necessary to study this observation adequately. Since a detay between appearance of MTC and other
endocrinopathies (five to 30 years) has been observed and the
age at tast negative screening is lower than the age for pheochromocytoma or hyperparathyroidism diagnosis, the absence
of associated endocrinopathies cannot be used to state definitively that MTC onty patients do not belong to the MEN 2A
classification.
Pathologic manifestations of MTC are different in sporadic
and hereditary forms. No significant difference was found in

Henry Ford Hosp Med J—Vol 37, Nos 3 & 4, 1989

Table 5
Comparison Between MEN 2A and MTC Only Families

Number of families
Investigated
subjects
Positive screening
for MTC
Positive screening
of associated
endocrinopathies
Negative screening
of associated
endocrinopathies

N
Mean age (years)
N
Mean age (years)
N
Mean age (years)
N
Mean age (years)

MTC Only

MEN 2A

7
72
31
2X
39
0

2
31
23
16
30
9
40

28
38

7
26

clinical manifestations. The resutts of this study will be used in
the study of other French MTC cases.
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